Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
These 5 Stocks Pay You Even When You're Sleeping
04:04pm, Thursday, 23'rd Apr 2026
Market volatility in 2026 has reminded investors that earned income alone is fragile.
Birch Hill Investment Advisors LLC Decreases Holdings in Johnson & Johnson $JNJ
05:46am, Thursday, 23'rd Apr 2026
Birch Hill Investment Advisors LLC trimmed its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 2.9% in the fourth quarter, according to the company in its most recent filing with the Securiti
First Horizon Corp Decreases Position in Johnson & Johnson $JNJ
04:36am, Thursday, 23'rd Apr 2026
First Horizon Corp lessened its stake in Johnson and Johnson (NYSE: JNJ) by 1.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm ow
Small Cap or Megacap: Which Healthcare Stock Is Right for You?
06:28pm, Wednesday, 22'nd Apr 2026
Healthcare companies with different market caps offer different rewards and challenges.
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
10:01am, Wednesday, 22'nd Apr 2026
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
J&J Innovative Medicine Drives Q1 Strength: Key to Long-Term Growth?
09:35am, Wednesday, 22'nd Apr 2026
JNJ's Innovative Medicine unit posts strong Q1 growth despite Stelara hit, with key drugs and new launches positioning the segment for long-term growth.
IMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG)
08:05am, Wednesday, 22'nd Apr 2026
Through 120 weeks of follow-up, IMAAVY delivered sustained clinical improvements and reductions in total IgG in antibody-positive adult patients including anti-AChR+ and anti-MuSK+ Patients achieving
Johnson & Johnson Announces CE Mark Approval for the New ETHICON™ 4000 Stapler
04:00am, Wednesday, 22'nd Apr 2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson announces that it has received European CE Mark approval for its new ETHICON™ 4000 Stapler.
Johnson & Johnson to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
04:22pm, Tuesday, 21'st Apr 2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will participate in the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19th. Management will participate in a
Johnson & Johnson Showcases CARTO-Powered Innovation, Including Debut of CARTOSOUND SONATA, to Advance Arrhythmia Care at HRS 2026
07:45am, Tuesday, 21'st Apr 2026
IRVINE, Calif.--(BUSINESS WIRE)--Johnson & Johnson showcases CARTO-powered innovation, including debut of CARTOSOUND SONATA, to advance arrhythmia care at HRS 2026.
Put $5,000 In These Dividend Giants and Earn Passive Income Every Quarter
12:35pm, Monday, 20'th Apr 2026
Earned income has a ceiling. Passive income from dividend stocks operates differently: cash flows in whether markets are up or down, whether you're working or sleeping.
How to Play J&J Stock Post a Beat-and-Raise Performance in Q1
10:16am, Monday, 20'th Apr 2026
Johnson & Johnson's JNJ first-quarter results were better than expected as it beat estimates for both earnings and sales. Despite the blockbuster drug, Stelara's loss of exclusivity (LOE), the Innova
Nations Financial Group Inc. IA ADV Acquires 3,604 Shares of Johnson & Johnson $JNJ
06:10am, Monday, 20'th Apr 2026
Nations Financial Group Inc. IA ADV increased its holdings in Johnson and Johnson (NYSE: JNJ) by 11.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securi
Lbp Am Sa Increases Stock Holdings in Johnson & Johnson $JNJ
05:34am, Monday, 20'th Apr 2026
Lbp Am Sa increased its stake in Johnson and Johnson (NYSE: JNJ) by 21.9% in the undefined quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 19
Johnson & Johnson $JNJ Shares Bought by KBC Group NV
05:34am, Monday, 20'th Apr 2026
KBC Group NV raised its holdings in Johnson and Johnson (NYSE: JNJ) by 21.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,296,831 shares
